title: Immunosuppression for lung transplantation.
abstract: As a result of advances in surgical techniques, immunosuppressive therapy, and postoperative management, lung transplantation has become an established therapeutic option for individuals with a variety of end-stage lung diseases. The current 1-year actuarial survival rate following lung transplantation is approximately 75%. However, the processes of acute and chronic lung allograft rejection have limited the long-term success of lung transplantation. Clinicians currently rely on a vast armamentarium of immunosuppressive agents to ameliorate graft rejection, but find themselves limited by an inescapable therapeutic paradox. Insufficient immunosuppression results in graft loss due to rejection, while excess immunosuppression results in increased morbidity and mortality from opportunistic infections and malignancies. Indeed, graft rejection, infection, and malignancy are the three principal causes of mortality for the lung transplant recipient. One should also keep in mind that graft loss in a lung transplant recipient is usually a fatal event, since there is no practical means of long-term mechanical support, and since the prospects of re-transplantation are low, given the shortage of acceptable donor grafts. This chapter reviews the current state of immunosuppressive therapy for lung transplantation, and suggests alternative paradigms for the management of future lung transplant recipients.
authors.affiliation: Division of Thoracic Surgery, the Transplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. jallan@partners.org
authors.forename: James S
authors.initials: JS
authors.lastname: Allan
mesh_terms: D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000276:immunology / Q000627:therapeutic use*; D016040:Lung Transplantation / Q000276:immunology*; D012131:Respiratory Insufficiency / Q000601:surgery; D023001:Transplantation Tolerance / Q000276:immunology
chemical_list: D007166:Immunosuppressive Agents